﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:blogChannel="Rss/rsscompary_2504.aspx"><channel><title> Press Releases from prbd.net</title><link>Rss/rsscompary_2504.aspx</link><description>prbd.net - Submit Press Release and get wide media coverage</description><copyright>Copyright 2011 prbd</copyright><item><title>Pharmaceutical Customer Relationship Management: Developing and Improving CRM</title><link>https://www.prbd.net/news_11763.aspx</link><description>As the pharmaceutical industry focuses on maximizing the lifetime value of customers and physicians, customer relationship management plays an increasingly important role. This study examines several top companies' CRM strategies and tactics to discover and analyze CRM best practices</description><pubDate>Mon, 08 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Deep Research Report on Global and China Offshore Wind Energy </title><link>https://www.prbd.net/news_11684.aspx</link><description>BharatBook adds report on "Deep Research Report on Global and China Offshore Wind Energy "it was a depth research report on Global and China Offshore Wind Farm operation. And thanks to the support and assistance from wind power experts and related enterprises during QYResearch Wind Energy team survey and interview.</description><pubDate>Thu, 04 Nov 2010 00:00:00 GMT</pubDate></item><item><title>China Solar Grade Wafer or Ingot Industry Chain Research Report  </title><link>https://www.prbd.net/news_11678.aspx</link><description>BharatBook adds report on "China Solar Grade Wafer or Ingot Industry Chain Research Report " it was a deep research report on china solar wafer industry chain and it was a good report for marketing or investment.</description><pubDate>Thu, 04 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Deep Research Report on China Clean Development Mechanism CDM Industry</title><link>https://www.prbd.net/news_11661.aspx</link><description>BharatBook adds report on " 2009 Deep Research Report on China Clean Development Mechanism (CDM) Industry"  was a professional and depth research report on China CDM Market</description><pubDate>Thu, 04 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Deep Research Report on Global and China PV Inverter Industry </title><link>https://www.prbd.net/news_11570.aspx</link><description>BharatBook adds report on "Deep Research Report on Global and China PV Inverter Industry " which introduced PV Inverter basic information such as grid off-grid string central pv inverter definition classification and manufacturing process product specifications.</description><pubDate>Wed, 03 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Driving Successful Pharma Brands Case Studies of Real Product Launches</title><link>https://www.prbd.net/news_11535.aspx</link><description>Would you like to take the guesswork out of spending on brand commercialization efforts? Are you sure when and how much to invest in brand promotional activities, market research, reimbursement efforts and medical affairs initiatives?</description><pubDate>Tue, 02 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Thought Leader Fair Market Value Compensation Benchmarks and Procedures</title><link>https://www.prbd.net/news_11531.aspx</link><description>Thought leader management teams face many new challenges in today’s environment. Academic institutions have implemented new regulations limiting or, in some cases, forbidding their faculty’s relationships with drug manufacturers.</description><pubDate>Tue, 02 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Key Opinion Leaders Relationship Management and Segmentation Data</title><link>https://www.prbd.net/news_11524.aspx</link><description>Increase thought leader participation and solidify opinion leader efforts: 
•	Plagued by low thought leader participation? 
•	Do your thought leader recruitment efforts feel scattershot or unproductive? 
•	Do you want to ensure that your documentation processes are fail-proof? 
</description><pubDate>Tue, 02 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Reinventing Pharmaceutical Sales Forces (PH127) </title><link>https://www.prbd.net/news_11516.aspx</link><description>For those companies stuck in the past, reducing sales force mirroring, creating more personal relationships with targets, and uncovering new ways to reach physicians are the orders of the day. The companies that will excel will be those that innovate now and find new avenues for connecting with targets and that develop relationships where doctors actually call on reps for information. </description><pubDate>Tue, 02 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Managing Clinical Investigator Compensation  </title><link>https://www.prbd.net/news_11500.aspx</link><description>Establishing transparent and defensible compensation processes for clinical investigators not only saves money - it is absolutely essential in today's restrictive pharma landscape. Regulatory groups, legislative bodies and consumer advocacy groups are applying relentless pressure on commercial relationships with physicians, altering and often limiting industry practices. </description><pubDate>Tue, 02 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Pharmaceutical Speaker Programs : Measuring ROI and Communicating Value</title><link>https://www.prbd.net/news_11439.aspx</link><description>Pharmaceutical Speaker Programs provides innovative, actionable strategies and best practices that will make your speaker events more effective and generate better ROI. Our data benchmarks - developed from input from marketing executives, brand managers, speaker programs directors among others - will anchor your decisions</description><pubDate>Mon, 01 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Pharmaceutical Mergers and Acquisitions</title><link>https://www.prbd.net/news_11433.aspx</link><description>Pharmaceutical Mergers and Acquisitions guides you to build an M&amp;A plan that focuses on key goals, avoids costly mistakes, and realizes deal potential as quickly as possible. CEI designed this study to identify the primary drivers of M&amp;A activity. Through the input of pharma industry leaders, our study provides solutions to the greatest M&amp;A pitfalls and gives clear, detailed insight of trends in pharmaceutical deals. The result: a roadmap to the M&amp;A landscape.</description><pubDate>Mon, 01 Nov 2010 00:00:00 GMT</pubDate></item><item><title>Pharmaceutical and Medical Device Regulatory Affairs</title><link>https://www.prbd.net/news_11401.aspx</link><description>Guarantee smooth approvals with a top-flight regulatory affairs team

Regulatory teams save time and money as they drive commercial and development goals forward. Build healthy relationships with - and receive clear direction from - regulatory agencies through early, consistent communication
</description><pubDate>Sat, 30 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Benchmarking Drug Safety and Pharmacovigilance</title><link>https://www.prbd.net/news_11388.aspx</link><description>This is a one-of-a-kind study dedicated exclusively to drug safety and pharmacovigilance. Benchmarking Drug Safety and Pharmacovigilance is a data-driven guide to optimizing your company's drug safety efforts. Designed for drug safety teams that work with clinical and post-marketed products, this study details budgets and outsourcing, structure and staffing, activities, timing, and communications</description><pubDate>Sat, 30 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Health Economics and Outcomes Research: US, Europe, Canada and Emerging Markets</title><link>https://www.prbd.net/news_11384.aspx</link><description>Gain instant access to detailed benchmarks and best practices that will streamline your health economics strategy. This one-of-a-kind study showcases the most up-to-date information on health economics and outcomes research (HEOR) goals and management. Five chapters are chock-full of data and expert advice focused on these primary areas:
•	Structure and reporting relationships 
•	Spending, budgets and ROI 
•	Staffing and compensation 
•	Activities, timelines and study costs </description><pubDate>Sat, 30 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Clinical Trial Patient Recruitment: Accelerate Enrollment, Increase Retention and Reduce Costs</title><link>https://www.prbd.net/news_11372.aspx</link><description>Clinical trial costs are skyrocketing amidst patient shortages, fewer drug approvals and limited growth in the number of available clinical investigators. At the same time, companies face stringent demands for more safety data — and patient recruitment stands as a pivotal roadblock</description><pubDate>Sat, 30 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Influencers on climate change &amp; social tipping points  </title><link>https://www.prbd.net/news_11354.aspx</link><description>This section report focuses on influencers - those people who are making an impact on public opinion concerning climate change. The analysis measures how much prominent influencers are considered to be effective in shaping opinion in Canada, England and the USA, and how much they are thought to be wrong-thinking and/or annoying</description><pubDate>Fri, 29 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Government mandates for action on climate change</title><link>https://www.prbd.net/news_11348.aspx</link><description>This section report addresses public agreement with the different types of policy that governments can use to tackle climate change. It presents evidence about how opinions differ by country, by attitudes towards climate change, party political support and other key demographics. Using cluster analysis, the public is categorized into six different groups according to their support for different types of policy. </description><pubDate>Fri, 29 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Green energy companies &amp; micro-CHP </title><link>https://www.prbd.net/news_11319.aspx</link><description>This section report focuses on specific companies that have developed, or are developing, low-carbon products and services for consumers - primarily for use in the home. Specifically, it considers opportunities for micro-generation, hydrogen fuel cells and green energy companies. </description><pubDate>Fri, 29 Oct 2010 00:00:00 GMT</pubDate></item><item><title>Carbon-offsetting &amp; business reputations  </title><link>https://www.prbd.net/news_11282.aspx</link><description>This section report has two focuses: carbon offsets and business reputations. The initial analysis is designed to understand the attitudes the public has towards carbon offsets, and how carbon offset schemes could build better public support. The analysis considers which demographic segments of the population are more, or less, supportive of carbon offsetting.</description><pubDate>Thu, 28 Oct 2010 00:00:00 GMT</pubDate></item><item><title>ADSL/Broadband Tariff tracker </title><link>https://www.prbd.net/news_9616.aspx</link><description>BharatBook added new report on "ADSL/Broadband Tariff tracker" which reveals the many different broadband offerings available in the 54 countries surveyed. </description><pubDate>Fri, 24 Sep 2010 00:00:00 GMT</pubDate></item><item><title>SmartPhone tariff Tracker </title><link>https://www.prbd.net/news_9615.aspx</link><description>BharatBook added new report on "SmartPhone tariff Tracker" which gives information about prices for BlackBerry, iPad and iPhone for over 100 operators across all regions..</description><pubDate>Fri, 24 Sep 2010 00:00:00 GMT</pubDate></item><item><title>London Data Centre Market 2010 to 2015 </title><link>https://www.prbd.net/news_9614.aspx</link><description>BharatBook added new report on "London Data Centre Market 2010 to 2015" which provide information about the key supply, demand and price trends that affect the London Data Centre Market.</description><pubDate>Fri, 24 Sep 2010 00:00:00 GMT</pubDate></item></channel></rss>